|Articles|June 2, 2022
LC-MS for detection of SARS-CoV-2
Author(s)Thermo Fisher Scientific
This technical note provides discovery to quantitation workflows for COVID-19-infected individuals by monitoring two biological matrices – plasma and nasopharyngeal swab
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
